BNP Paribas Financial Markets’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

BNP Paribas Financial Markets’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-829	Closed	-$10.3K	–	5757
2025 Q3	$10.3K	Sell	829 -50	-6%	-$763	﹤0.01%	5008
2025 Q2	$18.5K	Sell	879 -250	-22%	-$5.76K	﹤0.01%	4641
2025 Q1	$33.4K	Sell	1,129 -130	-10%	-$4.14K	﹤0.01%	4411
2024 Q4	$40.9K	Buy	+1,259	New	+$51.1K	﹤0.01%	4506
2023 Q1	–	Sell	-2	Closed	-$245	–	3874
2022 Q4	$245	Buy	+2	New	+$310	﹤0.01%	3912

Other funds holding CANF

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAM

Costello Asset Management Feasterville, Pennsylvania $333M AUM 25.99% 1-Year Est. Return

BNP Paribas Financial Markets's CANF Position: Q4 2025 in Review

BNP Paribas Financial Markets sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q4 2025, closing a stake of 829 shares — an estimated $10.3K sold.

BNP Paribas Financial Markets first reported a position in CANF in Q4 2022 and held it in 5 quarters. The position peaked at $40.9K in Q4 2024. 15 funds tracked by Wall St. Rank hold CANF as of Q4 2025.

BNP Paribas Financial Markets reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q4 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 829 Can-Fite BioPharma American Depositary Shares shares in Q4 2025, an estimated $10.3K.
BNP Paribas Financial Markets first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2022 and held it in 5 quarters.
BNP Paribas Financial Markets's Can-Fite BioPharma American Depositary Shares position peaked at $40.9K in Q4 2024.
15 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q4 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.